- Home
- Publications
- Publication Search
- Publication Details
Title
Gastroenteropancreatic Neuroendocrine Tumors
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 68, Issue 6, Pages 471-487
Publisher
American Cancer Society
Online
2018-10-08
DOI
10.3322/caac.21493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
- (2018) C. G. Genç et al. ANNALS OF SURGICAL ONCOLOGY
- Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors
- (2018) Marina Gorelik et al. SURGICAL CLINICS OF NORTH AMERICA
- Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival
- (2018) Kosmas Daskalakis et al. JAMA Oncology
- A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211).
- (2018) Pamela L. Kunz et al. JOURNAL OF CLINICAL ONCOLOGY
- Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases
- (2017) Anna Karpathakis et al. ENDOCRINE-RELATED CANCER
- Genetic and epigenetic drivers of neuroendocrine tumours (NET)
- (2017) Annunziata Di Domenico et al. ENDOCRINE-RELATED CANCER
- Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications
- (2017) Elettra Merola et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
- (2017) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
- (2017) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
- (2017) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors
- (2017) Mauro Cives et al. JNCI-Journal of the National Cancer Institute
- Whole-genome landscape of pancreatic neuroendocrine tumours
- (2017) Aldo Scarpa et al. NATURE
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
- (2017) Kjell Oberg et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
- (2017) Stefano Partelli et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
- (2017) Gregory Kaltsas et al. NEUROENDOCRINOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Usefulness of18F‐Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero‐Pancreatic Neuroendocrine Neoplasms
- (2017) Maria Rinzivillo et al. ONCOLOGIST
- The Surgical Management of Small Bowel Neuroendocrine Tumors
- (2017) James R. Howe et al. PANCREAS
- Neuroendocrine Tumors of the Stomach
- (2017) Britney Corey et al. SURGICAL CLINICS OF NORTH AMERICA
- Radionuclide Therapy for Neuroendocrine Tumors
- (2017) Mauro Cives et al. Current Oncology Reports
- Analysis of Postoperative Recurrence in Stage I–III Midgut Neuroendocrine Tumors
- (2017) Mauro Cives et al. JNCI-Journal of the National Cancer Institute
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Role of Interventional Radiology in the Treatment of Patients with Neuroendocrine Metastases in the Liver
- (2017) Larry K. Kvols et al. Journal of the National Comprehensive Cancer Network
- The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
- (2016) V. Mazzaferro et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Carcinoid heart disease: Diagnosis and management
- (2016) Sushil A. Luis et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
- (2016) Namrata Vijayvergia et al. BRITISH JOURNAL OF CANCER
- Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
- (2016) Malcolm Boyce et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
- (2016) Joo Young Kim et al. CLINICAL CANCER RESEARCH
- Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
- (2016) Aatur D. Singhi et al. CLINICAL CANCER RESEARCH
- Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
- (2016) M Cives et al. ENDOCRINE-RELATED CANCER
- MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
- (2016) J Cros et al. ENDOCRINE-RELATED CANCER
- Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
- (2016) Dik J. Kwekkeboom et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites
- (2016) Samira M. Sadowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
- (2016) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
- (2016) J.K. Ramage et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
- (2016) Anja Rinke et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
- (2016) G. Delle Fave et al. NEUROENDOCRINOLOGY
- Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs)
- (2016) Marybeth S. Hughes et al. SURGERY
- Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis
- (2016) Mary E. Condron et al. SURGERY
- Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement
- (2016) Joanne E Adaway et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors
- (2015) Joakim Crona et al. ANNALS OF SURGICAL ONCOLOGY
- The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
- (2015) Mauro Cives et al. DRUGS
- Frequency and Clinical Correlates of Somatic Ying Yang 1 Mutations in Sporadic Insulinomas
- (2015) Urs D. Lichtenauer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
- (2015) E. Skoura et al. JOURNAL OF NUCLEAR MEDICINE
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
- (2015) A. Sadanandam et al. Cancer Discovery
- Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
- (2014) Tetsuhide Ito et al. JOURNAL OF GASTROENTEROLOGY
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study
- (2014) J. R. Strosberg et al. ONCOLOGIST
- Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
- (2013) Robert L. Fine et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
- (2013) K. Oberg et al. CLINICAL CANCER RESEARCH
- Global DNA methylation patterns through an array-based approach in small intestinal neuroendocrine tumors
- (2013) Alberto Delgado Verdugo et al. ENDOCRINE-RELATED CANCER
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
- (2013) Ilaria Marinoni et al. GASTROENTEROLOGY
- The genomic landscape of small intestine neuroendocrine tumors
- (2013) Michaela S. Banck et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors
- (2013) Zhi Rong Qian et al. JOURNAL OF CLINICAL ONCOLOGY
- Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients
- (2013) Kristen Massimino et al. JOURNAL OF SURGICAL ONCOLOGY
- Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
- (2013) Rajesh V. Thakker MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- (2013) Joshua M Francis et al. NATURE GENETICS
- The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
- (2013) Hui-Jen Tsai et al. PLoS One
- Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1
- (2013) Yanan Cao et al. Nature Communications
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- Incidental Detection of Pancreatic Neuroendocrine Tumors: An Analysis of Incidence and Outcomes
- (2012) Asima Cheema et al. ANNALS OF SURGICAL ONCOLOGY
- FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide–platinum combination in patients with neuroendocrine carcinomas grade 3
- (2012) O Hentic et al. ENDOCRINE-RELATED CANCER
- Neuroendocrine tumor disease: an evolving landscape
- (2012) Andrea Frilling et al. ENDOCRINE-RELATED CANCER
- Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
- (2012) Jennifer A. Chan et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors
- (2012) Jonathan R. Strosberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
- (2012) Rim Cherif et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Current Size Criteria for the Management of Neuroendocrine Tumors of the Appendix: Are They Valid? Clinical Experience and Review of the Literature
- (2012) S. Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
- Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognized
- (2012) A. Rogers et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver
- (2011) Zhaohai Yang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor Size and Depth Predict Rate of Lymph Node Metastasis and Utilization of Lymph Node Sampling in Surgically Managed Gastric Carcinoids
- (2011) Mandeep S. Saund et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors
- (2011) Jonathan R. Strosberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Pancreatic endocrine tumors
- (2011) Sylvia L Asa MODERN PATHOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
- (2011) Y. Jiao et al. SCIENCE
- Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients
- (2010) Andrew S. Kennedy et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- Salvage Therapy with 177Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors
- (2010) M. van Essen et al. JOURNAL OF NUCLEAR MEDICINE
- The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)
- (2010) Lowell B. Anthony et al. PANCREAS
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
- (2009) Jonathan Strosberg et al. NEUROENDOCRINOLOGY
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
- 90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors
- (2008) Thomas K. Rhee et al. ANNALS OF SURGERY
- Liver disease induced by radioembolization of liver tumors
- (2008) Bruno Sangro et al. CANCER
- Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
- (2008) Dorota Dworakowska et al. ENDOCRINE-RELATED CANCER
- Tachykinins in endocrine tumors and the carcinoid syndrome
- (2008) Janet L Cunningham et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss
- (2008) Matthew H. Kulke et al. GENES CHROMOSOMES & CANCER
- Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastroenteropancreatic neuroendocrine tumours
- (2008) Irvin M Modlin et al. LANCET ONCOLOGY
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation